DNA
Ginkgo Bioworks Holdings
7.90$
+0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 0.0% | 20.4% | 41.3% | 42.7% | 21.5% | 17.0% | 18.5% | |
| 100.0% | 79.6% | 58.7% | 57.3% | 78.5% | 83.0% | 81.5% | |
| 177.7% | 208.4% | 366.3% | 220.4% | 230.9% | 186.8% | 143.3% | |
| 54.4% | 50.0% | 275.0% | 299.3% | 153.1% | 108.4% | 107.7% | |
| 232.1% | 258.4% | 641.3% | 519.7% | 422.3% | 329.6% | 266.8% | |
| -132.1% | -178.8% | -582.6% | -462.4% | -343.8% | -246.5% | -185.3% | |
| 4.5% | 3.1% | 0.8% | 0.0% | 0.0% | 0.0% | 0.0% | |
| -221.2% | -162.8% | -585.7% | -444.1% | -355.1% | -241.1% | -184.3% | |
| 0.0% | 2.5% | -0.5% | -3.1% | 0.0% | -0.2% | -0.5% | |
| -220.2% | -165.2% | -583.1% | -440.6% | -355.1% | -240.9% | -183.8% | |
| -196.8% | -141.7% | -575.7% | -431.2% | -326.6% | -213.3% | -149.6% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.